The global market for Tissue Engineering was valued at US$ 37850 million in the year 2024 and is projected to reach a revised size of US$ 122240 million by 2031, growing at a CAGR of 18.5% during the forecast period.
Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials.
Global Tissue Engineering key players include Allergan, Integra Lifesciences, C. R. Bard, etc. Global top three manufacturers hold a share over 70%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia Pacific, both have a share about 45 percent.
In terms of product, Biologically Derived Materials is the largest segment, with a share over 55%. And in terms of application, the largest application is Orthopedics, Musculoskeletal and Spine, followed by Skin and Integumentary, Cardiology and Vascular, Neurology, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tissue Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Engineering.
The Tissue Engineering market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tissue Engineering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Engineering manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Allergan
Integra Lifesciences
C. R. Bard
Zimmer Biomet
Organogenesis
Osiris Therapeutics
Cryolife
ACell
Biocomposites
DSM
Episkin
J-TEC
Athersys
Biotime
B. Braun
International Stem Cell
Bio Tissue Technologies
Segment by Type
Synthetic Materials
Biologically Derived Materials
Others
Segment by Application
Neurology
Cardiology and Vascular
Skin and Integumentary
Orthopedics, Musculoskeletal and Spine
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tissue Engineering manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tissue Engineering in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Tissue Engineering Market Overview
1.1 Product Definition
1.2 Tissue Engineering by Type
1.2.1 Global Tissue Engineering Market Value Comparison by Type (2024 VS 2031)
1.2.2 Synthetic Materials
1.2.3 Biologically Derived Materials
1.2.4 Others
1.3 Tissue Engineering by Application
1.3.1 Global Tissue Engineering Market Value by Application (2024 VS 2031)
1.3.2 Neurology
1.3.3 Cardiology and Vascular
1.3.4 Skin and Integumentary
1.3.5 Orthopedics, Musculoskeletal and Spine
1.3.6 Others
1.4 Global Tissue Engineering Market Size Estimates and Forecasts
1.4.1 Global Tissue Engineering Revenue 2020-2031
1.4.2 Global Tissue Engineering Sales 2020-2031
1.4.3 Global Tissue Engineering Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tissue Engineering Market Competition by Manufacturers
2.1 Global Tissue Engineering Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tissue Engineering Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tissue Engineering Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tissue Engineering, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tissue Engineering, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tissue Engineering, Product Type & Application
2.7 Global Key Manufacturers of Tissue Engineering, Date of Enter into This Industry
2.8 Global Tissue Engineering Market Competitive Situation and Trends
2.8.1 Global Tissue Engineering Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tissue Engineering Players Market Share by Revenue
2.8.3 Global Tissue Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tissue Engineering Market Scenario by Region
3.1 Global Tissue Engineering Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tissue Engineering Sales by Region: 2020-2031
3.2.1 Global Tissue Engineering Sales by Region: 2020-2025
3.2.2 Global Tissue Engineering Sales by Region: 2026-2031
3.3 Global Tissue Engineering Revenue by Region: 2020-2031
3.3.1 Global Tissue Engineering Revenue by Region: 2020-2025
3.3.2 Global Tissue Engineering Revenue by Region: 2026-2031
3.4 North America Tissue Engineering Market Facts & Figures by Country
3.4.1 North America Tissue Engineering Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tissue Engineering Sales by Country (2020-2031)
3.4.3 North America Tissue Engineering Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tissue Engineering Market Facts & Figures by Country
3.5.1 Europe Tissue Engineering Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tissue Engineering Sales by Country (2020-2031)
3.5.3 Europe Tissue Engineering Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tissue Engineering Market Facts & Figures by Region
3.6.1 Asia Pacific Tissue Engineering Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tissue Engineering Sales by Region (2020-2031)
3.6.3 Asia Pacific Tissue Engineering Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tissue Engineering Market Facts & Figures by Country
3.7.1 Latin America Tissue Engineering Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tissue Engineering Sales by Country (2020-2031)
3.7.3 Latin America Tissue Engineering Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tissue Engineering Market Facts & Figures by Country
3.8.1 Middle East and Africa Tissue Engineering Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tissue Engineering Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tissue Engineering Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tissue Engineering Sales by Type (2020-2031)
4.1.1 Global Tissue Engineering Sales by Type (2020-2025)
4.1.2 Global Tissue Engineering Sales by Type (2026-2031)
4.1.3 Global Tissue Engineering Sales Market Share by Type (2020-2031)
4.2 Global Tissue Engineering Revenue by Type (2020-2031)
4.2.1 Global Tissue Engineering Revenue by Type (2020-2025)
4.2.2 Global Tissue Engineering Revenue by Type (2026-2031)
4.2.3 Global Tissue Engineering Revenue Market Share by Type (2020-2031)
4.3 Global Tissue Engineering Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tissue Engineering Sales by Application (2020-2031)
5.1.1 Global Tissue Engineering Sales by Application (2020-2025)
5.1.2 Global Tissue Engineering Sales by Application (2026-2031)
5.1.3 Global Tissue Engineering Sales Market Share by Application (2020-2031)
5.2 Global Tissue Engineering Revenue by Application (2020-2031)
5.2.1 Global Tissue Engineering Revenue by Application (2020-2025)
5.2.2 Global Tissue Engineering Revenue by Application (2026-2031)
5.2.3 Global Tissue Engineering Revenue Market Share by Application (2020-2031)
5.3 Global Tissue Engineering Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Tissue Engineering Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Integra Lifesciences
6.2.1 Integra Lifesciences Company Information
6.2.2 Integra Lifesciences Description and Business Overview
6.2.3 Integra Lifesciences Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Integra Lifesciences Tissue Engineering Product Portfolio
6.2.5 Integra Lifesciences Recent Developments/Updates
6.3 C. R. Bard
6.3.1 C. R. Bard Company Information
6.3.2 C. R. Bard Description and Business Overview
6.3.3 C. R. Bard Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.3.4 C. R. Bard Tissue Engineering Product Portfolio
6.3.5 C. R. Bard Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Company Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zimmer Biomet Tissue Engineering Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Organogenesis
6.5.1 Organogenesis Company Information
6.5.2 Organogenesis Description and Business Overview
6.5.3 Organogenesis Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Organogenesis Tissue Engineering Product Portfolio
6.5.5 Organogenesis Recent Developments/Updates
6.6 Osiris Therapeutics
6.6.1 Osiris Therapeutics Company Information
6.6.2 Osiris Therapeutics Description and Business Overview
6.6.3 Osiris Therapeutics Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Osiris Therapeutics Tissue Engineering Product Portfolio
6.6.5 Osiris Therapeutics Recent Developments/Updates
6.7 Cryolife
6.7.1 Cryolife Company Information
6.7.2 Cryolife Description and Business Overview
6.7.3 Cryolife Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cryolife Tissue Engineering Product Portfolio
6.7.5 Cryolife Recent Developments/Updates
6.8 ACell
6.8.1 ACell Company Information
6.8.2 ACell Description and Business Overview
6.8.3 ACell Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ACell Tissue Engineering Product Portfolio
6.8.5 ACell Recent Developments/Updates
6.9 Biocomposites
6.9.1 Biocomposites Company Information
6.9.2 Biocomposites Description and Business Overview
6.9.3 Biocomposites Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biocomposites Tissue Engineering Product Portfolio
6.9.5 Biocomposites Recent Developments/Updates
6.10 DSM
6.10.1 DSM Company Information
6.10.2 DSM Description and Business Overview
6.10.3 DSM Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DSM Tissue Engineering Product Portfolio
6.10.5 DSM Recent Developments/Updates
6.11 Episkin
6.11.1 Episkin Company Information
6.11.2 Episkin Description and Business Overview
6.11.3 Episkin Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Episkin Tissue Engineering Product Portfolio
6.11.5 Episkin Recent Developments/Updates
6.12 J-TEC
6.12.1 J-TEC Company Information
6.12.2 J-TEC Description and Business Overview
6.12.3 J-TEC Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.12.4 J-TEC Tissue Engineering Product Portfolio
6.12.5 J-TEC Recent Developments/Updates
6.13 Athersys
6.13.1 Athersys Company Information
6.13.2 Athersys Description and Business Overview
6.13.3 Athersys Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Athersys Tissue Engineering Product Portfolio
6.13.5 Athersys Recent Developments/Updates
6.14 Biotime
6.14.1 Biotime Company Information
6.14.2 Biotime Description and Business Overview
6.14.3 Biotime Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Biotime Tissue Engineering Product Portfolio
6.14.5 Biotime Recent Developments/Updates
6.15 B. Braun
6.15.1 B. Braun Company Information
6.15.2 B. Braun Description and Business Overview
6.15.3 B. Braun Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.15.4 B. Braun Tissue Engineering Product Portfolio
6.15.5 B. Braun Recent Developments/Updates
6.16 International Stem Cell
6.16.1 International Stem Cell Company Information
6.16.2 International Stem Cell Description and Business Overview
6.16.3 International Stem Cell Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.16.4 International Stem Cell Tissue Engineering Product Portfolio
6.16.5 International Stem Cell Recent Developments/Updates
6.17 Bio Tissue Technologies
6.17.1 Bio Tissue Technologies Company Information
6.17.2 Bio Tissue Technologies Description and Business Overview
6.17.3 Bio Tissue Technologies Tissue Engineering Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bio Tissue Technologies Tissue Engineering Product Portfolio
6.17.5 Bio Tissue Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tissue Engineering Industry Chain Analysis
7.2 Tissue Engineering Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tissue Engineering Production Mode & Process Analysis
7.4 Tissue Engineering Sales and Marketing
7.4.1 Tissue Engineering Sales Channels
7.4.2 Tissue Engineering Distributors
7.5 Tissue Engineering Customer Analysis
8 Tissue Engineering Market Dynamics
8.1 Tissue Engineering Industry Trends
8.2 Tissue Engineering Market Drivers
8.3 Tissue Engineering Market Challenges
8.4 Tissue Engineering Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Allergan
Integra Lifesciences
C. R. Bard
Zimmer Biomet
Organogenesis
Osiris Therapeutics
Cryolife
ACell
Biocomposites
DSM
Episkin
J-TEC
Athersys
Biotime
B. Braun
International Stem Cell
Bio Tissue Technologies
听
听
*If Applicable.
